Money is not flowing into CV sciences because of a potential listing in my opinion. It’s the phenomenal growth that’s driving SP Appreciationin addition to CBD news spreading across all media formats
Well we have gone from 20 cents to almost six bucks on the otc. Cv sciences has market share and will be just fine making millions and millions right where we are! Just look at the vitamin industry and how many players and brands there are and they all do just fine. The only reason the company wanted to uplist to the Nasdaq is for acess to capital since they will need tons of money if they continue to pursue the 007 drug....
Umm... the company has done amazing so far without an uplisting. So the scenario would most likely be one where they continue to be amazing without an uplisting.